PDB Short entry for 2W3L HEADER APOPTOSIS 13-NOV-08 2W3L TITLE CRYSTAL STRUCTURE OF CHIMAERIC BCL2-XL AND PHENYL TITLE 2 TETRAHYDROISOQUINOLINE AMIDE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 9-33,92-206; COMPND 5 SYNONYM: BCL2-XL; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR J.PORTER,A.PAYNE,B.DE CANDOLE,D.FORD,B.HUTCHINSON,G.TREVITT,J.TURNER, AUTHOR 2 C.EDWARDS,C.WATKINS,I.WHITCOMBE,J.DAVIS,C.STUBBERFIELD,M.FISHER, AUTHOR 3 M.LAMERS REVDAT 3 28-JUN-17 2W3L 1 REMARK REVDAT 2 23-DEC-08 2W3L 1 JRNL REVDAT 1 09-DEC-08 2W3L 0 JRNL AUTH J.PORTER,A.PAYNE,B.DE CANDOLE,D.FORD,B.HUTCHINSON,G.TREVITT, JRNL AUTH 2 J.TURNER,C.EDWARDS,C.WATKINS,I.WHITCOMBE,J.DAVIS, JRNL AUTH 3 C.STUBBERFIELD JRNL TITL TETRAHYDROISOQUINOLINE AMIDE SUBSTITUTED PHENYL PYRAZOLES AS JRNL TITL 2 SELECTIVE BCL-2 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 230 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19027294 JRNL DOI 10.1016/J.BMCL.2008.10.113 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 18688 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1012 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1340 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2318 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 223 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.91000 REMARK 3 B22 (A**2) : -1.96000 REMARK 3 B33 (A**2) : -0.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.261 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.210 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.149 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.425 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2476 ; 0.018 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3357 ; 1.718 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 279 ; 6.395 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 133 ;31.187 ;22.632 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 370 ;16.501 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;15.933 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 327 ; 0.118 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1987 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1204 ; 0.213 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1702 ; 0.316 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 263 ; 0.242 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 68 ; 0.204 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 30 ; 0.257 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1435 ; 1.253 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2224 ; 1.976 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1234 ; 3.095 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1133 ; 4.798 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2W3L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1290038090. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARIMAX-HF REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU (RAXIS4) REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22774 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 19.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.010 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.970 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.33500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.16000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.33500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.16000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 33 REMARK 465 ALA A 34 REMARK 465 ASP A 35 REMARK 465 SER B 164 REMARK 465 MET B 165 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 12 CZ NH1 NH2 REMARK 470 LYS A 17 CG CD CE NZ REMARK 470 GLN A 25 CD OE1 NE2 REMARK 470 LYS A 54 CE NZ REMARK 470 LYS B 17 CG CD CE NZ REMARK 470 ARG B 26 CD NE CZ NH1 NH2 REMARK 470 ARG B 65 CG CD NE CZ NH1 NH2 REMARK 470 SER B 76 CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2019 O HOH A 2020 2.14 REMARK 500 O GLU A 124 O HOH A 2095 2.17 REMARK 500 OE1 GLN A 149 O HOH A 2108 2.19 REMARK 500 OH TYR B 18 OE2 GLU B 111 2.19 REMARK 500 OE1 GLU A 119 O HOH A 2092 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2056 O HOH B 2025 2564 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 76 61.90 -57.59 REMARK 500 HIS A 79 51.88 38.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR B 161 GLY B 162 47.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2021 DISTANCE = 6.56 ANGSTROMS REMARK 525 HOH B2019 DISTANCE = 6.22 ANGSTROMS REMARK 525 HOH B2024 DISTANCE = 6.32 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DRO A1166 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DRO B1164 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YSW RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2COMPLEXED REMARK 900 WITH AN ACYL- SULFONAMIDE-BASED LIGAND REMARK 900 RELATED ID: 1G5M RELATED DB: PDB REMARK 900 HUMAN BCL-2, ISOFORM 1 REMARK 900 RELATED ID: 1GJH RELATED DB: PDB REMARK 900 HUMAN BCL-2, ISOFORM 2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS SUGGEST THE FLEXIBLE LOOP BETWEEN N- AND C-TERMINUS REMARK 999 IS A CHIMERA DBREF 2W3L A 9 33 UNP P10415 BCL2_HUMAN 9 33 DBREF 2W3L A 34 50 PDB 2W3L 2W3L 34 50 DBREF 2W3L A 51 165 UNP P10415 BCL2_HUMAN 92 206 DBREF 2W3L B 9 33 UNP P10415 BCL2_HUMAN 9 33 DBREF 2W3L B 34 50 PDB 2W3L 2W3L 34 50 DBREF 2W3L B 51 165 UNP P10415 BCL2_HUMAN 92 206 SEQADV 2W3L LYS A 54 UNP P10415 LEU 95 CONFLICT SEQADV 2W3L GLU A 58 UNP P10415 GLN 99 CONFLICT SEQADV 2W3L GLY A 77 UNP P10415 GLN 118 CONFLICT SEQADV 2W3L LYS B 54 UNP P10415 LEU 95 CONFLICT SEQADV 2W3L GLU B 58 UNP P10415 GLN 99 CONFLICT SEQADV 2W3L GLY B 77 UNP P10415 GLN 118 CONFLICT SEQRES 1 A 144 TYR ASP ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR SEQRES 2 A 144 LYS LEU SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ALA SEQRES 3 A 144 ASP SER GLU VAL VAL HIS LYS THR LEU ARG GLU ALA GLY SEQRES 4 A 144 ASP ASP PHE SER ARG ARG TYR ARG ARG ASP PHE ALA GLU SEQRES 5 A 144 MET SER SER GLY LEU HIS LEU THR PRO PHE THR ALA ARG SEQRES 6 A 144 GLY ARG PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP SEQRES 7 A 144 GLY VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE SEQRES 8 A 144 GLY GLY VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SEQRES 9 A 144 SER PRO LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU SEQRES 10 A 144 TYR LEU ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN SEQRES 11 A 144 GLY GLY TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER SEQRES 12 A 144 MET SEQRES 1 B 144 TYR ASP ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR SEQRES 2 B 144 LYS LEU SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ALA SEQRES 3 B 144 ASP SER GLU VAL VAL HIS LYS THR LEU ARG GLU ALA GLY SEQRES 4 B 144 ASP ASP PHE SER ARG ARG TYR ARG ARG ASP PHE ALA GLU SEQRES 5 B 144 MET SER SER GLY LEU HIS LEU THR PRO PHE THR ALA ARG SEQRES 6 B 144 GLY ARG PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP SEQRES 7 B 144 GLY VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE SEQRES 8 B 144 GLY GLY VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SEQRES 9 B 144 SER PRO LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU SEQRES 10 B 144 TYR LEU ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN SEQRES 11 B 144 GLY GLY TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER SEQRES 12 B 144 MET HET DRO A1166 42 HET DRO B1164 42 HETNAM DRO 1-(2-{[(3S)-3-(AMINOMETHYL)-3,4-DIHYDROISOQUINOLIN- HETNAM 2 DRO 2(1H)-YL]CARBONYL}PHENYL)-4-CHLORO-5-METHYL-N,N- HETNAM 3 DRO DIPHENYL-1H-PYRAZOLE-3-CARBOXAMIDE FORMUL 3 DRO 2(C34 H30 CL N5 O2) FORMUL 5 HOH *223(H2 O) HELIX 1 1 ASP A 10 ARG A 26 1 17 HELIX 2 2 SER A 49 TYR A 67 1 19 HELIX 3 3 TYR A 67 SER A 76 1 10 HELIX 4 4 THR A 84 PHE A 97 1 14 HELIX 5 5 ASN A 102 ARG A 123 1 22 HELIX 6 6 PRO A 127 LEU A 144 1 18 HELIX 7 7 LEU A 144 ASN A 151 1 8 HELIX 8 8 GLY A 153 TYR A 161 1 9 HELIX 9 9 ASP B 10 GLN B 25 1 16 HELIX 10 10 SER B 49 TYR B 67 1 19 HELIX 11 11 TYR B 67 SER B 76 1 10 HELIX 12 12 THR B 84 ARG B 98 1 15 HELIX 13 13 ASN B 102 ARG B 123 1 22 HELIX 14 14 PRO B 127 LEU B 144 1 18 HELIX 15 15 LEU B 144 ASN B 151 1 8 HELIX 16 16 GLY B 153 GLY B 162 1 10 SITE 1 AC1 9 PHE A 63 TYR A 67 ASP A 70 MET A 74 SITE 2 AC1 9 VAL A 92 GLU A 95 LEU A 96 ALA A 108 SITE 3 AC1 9 PHE A 112 SITE 1 AC2 10 PHE B 63 TYR B 67 ASP B 70 PHE B 71 SITE 2 AC2 10 MET B 74 GLU B 95 LEU B 96 ALA B 108 SITE 3 AC2 10 PHE B 112 HOH B2102 CRYST1 68.000 68.320 70.670 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014706 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014637 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014150 0.00000